TrialJournal for immunotherapy of cancer2024

Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: a phase 3 trial.

Zhiming Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.